Blogs
Orphan Drug Pricing: Is Eurordis call to reduce prices by 3-5 times the answer to unequitable access?
Partners4Access comments on the new Eurordis Position Paper Earlier this month Eurordis published its position paper on orphan drug access. Whilst the report is commendable